Lifetime Estrogen Exposure Tied to Cortical Thickness in Memory Regions Among Women 65-80

University of Kansas researchers performed cross-sectional structural MRI and collected detailed reproductive histories to quantify three sources of estrogen exposure. Later menopause age correlated with thicker cortex in the left middle occipital gyrus and other Alzheimer's-vulnerable regions; prior contraceptive and menopausal hormone therapy use each independently predicted larger volumes in memory and information-processing circuits. The design cannot separate selection effects from causation, yet the pattern aligns with estrogen's documented roles in neuronal maintenance and vascular integrity.

The 2002 Women's Health Initiative trial curtailed menopausal hormone therapy prescriptions after reporting early harm signals, yet subsequent re-analyses and observational cohorts have suggested timing-dependent benefits when therapy begins near menopause. The Kansas data extend this discussion by implicating adolescent and young-adult contraceptive exposure, an interval rarely examined in neurodegeneration research. This lifetime perspective highlights a potential window for risk modification decades before clinical cognitive decline.

Women comprise nearly two-thirds of Alzheimer's cases; clarifying whether early and sustained estrogen exposure modifies white-matter integrity or amyloid trajectories requires prospective cohorts that track hormone use from reproductive years through late life. Next-step studies must incorporate APOE genotype, vascular imaging, and incident dementia endpoints to test whether the observed structural associations translate into measurable risk reduction.